Yelin ChenFounder at Synphatec (Shanghai) Biopharmaceutical TechnologyPresenter
Profile
Founded in 2022 in Shanghai, foucusing on CNS therapeutic area Leading Assets: Fast-Antidepressant & Broad spectrum AD therapeutics Has accumulated over $13 million in financing Drug discovery based on the understanding of brain disease biology or drug mechanism from the founder’s lab Exclusive intelligent property rights officially transferred to the company
Agenda Sessions
CNS/Neurology: Synphatec (Shanghai) Biopharmaceutical Technology
, 15:30View Session